In this issue:
Renal effects of dapagliflozin in type 1 diabetes with albuminuria
Once-weekly insulin icodec regimens in type 2 diabetes
Outcomes in diabetics after hospitalisation for COVID-19
Erectile function in men with type 2 diabetes treated with dulaglutide
Imatinib for recent-onset type 1 diabetes
Tirzepatide vs. placebo or semaglutide for type 2 diabetes
Long-term complications of youth-onset type 2 diabetes
Please login below to download this issue (PDF)